BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanisms.
Dinter L, Karitzky PC, Schulz A, Wurm AA, Mehnert MC, Sergon M, Tunger A, Lesche M, Wehner R, Müller A, Käubler T, Niessner H, Dahl A, Beissert S, Schmitz M, Meier F, Seliger B, Westphal D.
Dinter L, et al. Among authors: beissert s.
Int J Cancer. 2024 Mar 15;154(6):1057-1072. doi: 10.1002/ijc.34807. Epub 2023 Dec 11.
Int J Cancer. 2024.
PMID: 38078628